ロード中...
Improved renal recovery in patients with atypical hemolytic uremic syndrome following rapid initiation of eculizumab treatment
BACKGROUND: Eculizumab is approved for atypical hemolytic uremic syndrome (aHUS). Guidelines discuss the importance of prompt treatment. We report a post hoc analysis investigating the effect of baseline factors, including patient characteristics and time from the latest aHUS manifestation to eculiz...
保存先:
| 出版年: | J Nephrol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5316393/ https://ncbi.nlm.nih.gov/pubmed/26995002 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40620-016-0288-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|